Showing results (211-220 of 1,348) with videos related to

Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|July 17, 2020
Evaluation of the Potential for QTc Prolongation With Repeated Oral Doses of Fedratinib in Patients With Advanced Solid TumorsKen Ogasawara, Christine Xu, Jian Yin, et al.
Clinical Pharmacology in Drug Development|May 1, 2023
Comparison of Two Manufacturing Processes of Daprodustat for Bioequivalence and Dissolution in Healthy Volunteers: A Randomized Crossover StudyBonnie Shaddinger, Kelly M Mahar, Mike Sprys, et al.
Clinical Pharmacology in Drug Development|May 11, 2023
Pharmacokinetics and Pharmacodynamics of Lansoprazole/Sodium Bicarbonate Immediate-release Capsules in Healthy Chinese Subjects: An Open, Randomized, Controlled, Crossover, Single-, and Multiple-dose TrialLixiu Yu, Xuejia Zhai, Sanlan Wu, et al.
Clinical Pharmacology in Drug Development|May 21, 2023
Pharmacokinetics and Safety of Coadministered Atogepant and Topiramate in Healthy Participants: A Phase 1, Open-Label, Drug-Drug Interaction StudyRamesh Boinpally, Danielle McGeeney, Lisa Borbridge, et al.
Clinical Pharmacology in Drug Development|April 20, 2021
Human Mass Balance and Metabolite Profiling of [14 C]-Pamiparib, a Poly (ADP-Ribose) Polymerase Inhibitor, in Patients With Advanced CancerSong Mu, Daniel Palmer, Richard Fitzgerald, et al.
Clinical Pharmacology in Drug Development|April 17, 2021
Pharmacokinetics of Opicapone and Its Metabolites in Healthy White and Chinese SubjectsWei Xue, Yan Tan, Yue Liu, et al.
Clinical Pharmacology in Drug Development|July 25, 2020
Parameter Estimation and Reporting in Noncompartmental Analysis of Clinical Pharmacokinetic DataDennis A Noe
Clinical Pharmacology in Drug Development|July 7, 2020
A Randomized, Double-Blind Study Comparing Pharmacokinetics and Pharmacodynamics of Proposed Biosimilar ABP 798 With Rituximab Reference Product in Subjects With Moderate to Severe Rheumatoid ArthritisGerd Burmester, David Chien, Vincent Chow, et al.
Clinical Pharmacology in Drug Development|February 25, 2023
The Oral Bioavailability and Effect of Various Gastric Conditions on the Pharmacokinetics of Dersimelagon in Healthy Adult VolunteersKei Ogawa, Ryosuke Ide, Kirstine Belongie, et al.
Clinical Pharmacology in Drug Development|August 21, 2022
Phase 1 Study to Investigate the Safety, Tolerability, and Pharmacokinetics of EPI-589 in Healthy ParticipantsNaoto Noda, Tatsuto Hamatani, Yuta Shibue, et al.
Pageof 135